Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
From the Journals
Multidrug-resistant gram-negative infections treatable with newer antibiotics, but guidance is needed
They found that these infections were the second leading cause of death worldwide.
COVID-19 has lifted the lid on the risks of secondary pulmonary fungal infections.
The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying,
News from the FDA/CDC
Thanksgiving travel seems to have had little effect on new pediatric cases.
The findings are not consistent with those of many other studies on this topic.
Several common pediatric conditions do not require diagnostic tests.
The drug is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
The parents of the child who had a severe case of RSV reflected on the their son’s bout with the illness.
But the vaccine’s effectiveness decreased over time.
“The right drug at the right time with the right dose for the right bug for the right duration.”